Single-Patient Clinical Trial Policy under Development at FDA

June 12, 2019

The Food and Drug Administration (FDA) is “rushing” to establish policies for clinical trials to test therapies tailored for a single patient, the agency’s drug chief said on June 4.

Related Stories